Conditions: Glaucoma Ocular Hypertension
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 597
Healthy volunteers: no

Brief summary:
This study will evaluate the safety and efficacy of bimatoprost 0.03% formulation B ophthalmic solution with LUMIGAN® (bimatoprost ophthalmic solution 0.03%) once daily for 12 weeks in patients with glaucoma or ocular hypertension

Detailed description:

Arms:
arm 1: Bimatoprost 0.03% Formulation B Ophthalmic Solution arm 2: Bimatoprost 0.03% Ophthalmic Solution

Interventions: intervention 1: Bimatoprost 0.03% Formulation B Ophthalmic Solution intervention 2: Bimatoprost 0.03% Ophthalmic Solution
Intervention descriptions: intervention 1: One drop administered in each eye, every evening, for 12 weeks intervention 2: One drop administered in each eye, every evening, for 12 weeks

Protocol document: